Naga Chalasani

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Community Dwelling

Alcohol Consumption

Top Venues

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Danielle Brandman, Marie Boyle, McPherson Stuart, Mark L Van Natta, Arun J Sanyal, Kris Kowdley, Brent Neuschwander-Tetri, Naga Chalasani, Manal F Abdelmalek, Norah A Terrault, Art McCullough, Ricki Bettencourt, Cyrielle Caussy, David E Kleiner, Cynthia Behling, James Tonascia, Quentin Mark Anstee, Stephen Caldwell
Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' reply. Alimentary pharmacology & therapeutics 56 (1) (2022)
Eduardo Vilar-Gomez, Naga Chalasani
Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Authors' reply. Alimentary pharmacology & therapeutics 50 (7) (2020)
Eduardo Vilar-Gomez, Naga Chalasani
Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease. Authors' reply. Alimentary pharmacology & therapeutics 50 (7) (2020)
Niharika R Samala, Samer Gawrieh, Qing Tang, Spencer G Lourens, Vijay H Shah, Arun J Sanyal, Suthat Liangpunsakul, Naga Chalasani
Clinical Characteristics and Outcomes of Mild to Moderate Alcoholic Hepatitis. GastroHep 1 (4) (2019)
Eduardo Vilar-Gomez, Raj Vuppalanchi, Archita P Desai, Samer Gawrieh, Marwan S Ghabril, Romil Saxena, Oscar W Cummings, Naga Chalasani
Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis. Alimentary pharmacology & therapeutics 50 (3) (2019)